Inbio Ventures

Moscow Russia (HQ)
Investor type VC
Founded 2013
AUM $300 M
Location Russia

Profile

Over $200m deployed in early stage biotech companies through investments and strategic deals. 360˚ knowledge of the sector. Evolution stages: Academia, In-house Industrial R&D, Corporate VC and Business Development, Professional Regulated Public Equities Asset Management. Top positions in venture and production biotech companies in USA, Russia, Canada, EU: Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, Transmedics and others Inbio ventures is looking for innovative drug discovery/development projects targeting the unmet medical needs or providing dramatic advantages over the competition globally.
Therapeutic areas of the highest priority are the following:
-Oncology
-Inflammation
-Autoimmune diseases
-Orphan genetic diseases
-Critical care
-Cell-based therapy and regenerative medicine
-Stage of development

The project, ideally, should at least have passed the in-vivo proof-of-concept (PoC), and should have a strong scientific background behind it. Management team with appropriate experience is a substantial advantage.

Industry focus

Pharmaceuticals Biotechnology Healthcare Services Medical Devices MedTech Technology Life Sciences

Investment preferences

Investment Ticket

$1-5 m

Investment Horizon

3-5 years

Investment Stage

Growth

Exit Strategy

Acquisition

Region focus

North America Europe

Contacts

Name
Title
E-mail
Social

Name

Name

Title

Title

E-mail

email@email.com

Social

Name

Name

Title

Title

E-mail

email@email.com

Social

Name

Name

Title

Title

E-mail

email@email.com

Social

If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!